COVID-19

Early data suggests vaccines are effective against B.1.617.2 variant first discovered in India.

The anticoagulant did not improve clinical outcomes when compared with prophylactic anticoagulation.

A cardiologist and wellness expert discusses new findings showing more than one-third of her peers were burnt out from experiences during the pandemic.

DARE-19 data show a slight improvement in outcomes among hospitalized COVID-19 patients receiving the SGLT-2 inhibitor—showing the cardiovascular drug class is safe in patients with the pandemic virus.

Vaccinated individuals no longer need to wear masks indoors in accordance with CDC guidance.

Data show a nearly 30% reduction in individuals filling naloxone prescriptions at the start of COVID-19 pandemic, with no significant recovery observed.

Prescription rates of buprenorphine and opioid analgesics for OUD fell during the COVID-19 pandemic for new patients, but existing treatment was not affected.

More than 3000 people per day in India have died of COVID-19 since April 28.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Dr. Todd Hutton gives tips for how to best handle the ongoing mental health crisis.

New data show NSAIDs treatment not associated with worse in-hospital mortality rates compared to patients not treated with NSAIDs.

A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.

New data show rheumatoid arthritis and immunosuppressive treatment associated with more severe risks of COVID-19, including hospitalization and death.

The companies announce plans to submit a Biologics License Agreement for the mRNA-based vaccine.

New data show immunosuppressant treatment did not increase susceptibility to or severity of COVID-19 in patients with immune-mediated inflammatory disease

Patients with nAMD, DME, and RVO received fewer intravitreal injections between pre- and post-lockdown periods.

Nearly a third of the US population has been fully vaccinated.

Dr. Joshua Morganstein discusses the psychological impacts disasters can have on individuals and how the COVID-19 pandemic might be different than other disasters.

The US will send unused vaccines to India to help combat the growing pandemic.

Esther Freeman, MD, PhD, discusses the most frequent cutaneous presentations associated with vaccination.

A study out of Boston observes little to no difference in previous biologic prescription and worsened odds of infection nor death during the pandemic.

Esther Freeman, MD, PhD, talks about the various levels of dermatologic severity associated with COVID-19.

COVID-19 patients receiving at least 2 antibiotics were at a higher CDI risk.

Dr. Jennifer Payne discusses how the events of the last year has impacted her patients and what needs to happen to improve mental health care in the future.

Dr. Anthony Fauci believes the Johnson & Johnson vaccine pause will soon end.

An expert discusses the continued need to clarify COVID-19-related thrombosis risks as well as ensuring patients receive the most accurate information.

Maria DeSancho, MD, talks personal experiences with patients, vaccine hesitancy, mRNA versus adenovirus technology, risks and types of thrombosis, and more.

A thrombosis expert details cerebral venous thrombosis, the side effect reported in a half-dozen women administered the Johnson & Johnson vaccine.

FDA, CDC recommended halting use of the one-shot vaccine at all federal sites.

Cases continue to surge across the globe in several countries including India and Pakistan.